| Literature DB >> 20464221 |
Ma Eugenia Jiménez-Corona1, Lourdes García-García, Alfredo Ponce de León, Miriam Bobadilla-del Valle, Martha Torres, Sergio Canizales-Quintero, Carmen Palacios-Merino, Susana Molina-Hernández, Rosa Areli Martínez-Gamboa, Luis Juárez-Sandino, Bulmaro Cano-Arellano, Leticia Ferreyra-Reyes, Luis Pablo Cruz-Hervert, Renata Báez-Saldaña, Elizabeth Ferreira-Guerrero, Eduardo Sada, Brenda Marquina, José Sifuentes-Osornio.
Abstract
This study describes the achievements of the Mexican Consortium against Tuberculosis, in the Sanitary District of Orizaba, Veracruz, Mexico between 1995 and 2008. In brief, the main results can be classified as follows: 1) Conventional and molecular epidemiology (measurement of burden of disease, trends, risk factors and vulnerable groups, consequences of drug resistance, identification of factors that favor nosocomial and community transmission); 2) Development of diagnostic techniques to detect drug resistance, description of circulating clones and adaptation of simple techniques to be used in the field; 3) Evaluation of usefulness of tuberculin skin test, immunologic responses to BCG, impact of directly observed therapy for tuberculosis (DOTS), and study of immunological biomarkers and 4) Comments on ethical aspects of tuberculosis research. Additionally, we describe the impact on public policies, transference of technology, capacity building and future perspectives.Entities:
Mesh:
Year: 2009 PMID: 20464221
Source DB: PubMed Journal: Salud Publica Mex ISSN: 0036-3634